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Abstract
Background: Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), is a facultative intracellular
pathogen that can persist within the host. The bacteria are thought to be in a state of reduced replication and metabolism
as part of the chronic lung infection. Many in vitro studies have dissected the hypothesized environment within the infected
lung, defining the bacterial response to pH, starvation and hypoxia. While these experiments have afforded great insight,
the picture remains incomplete. The only way to study the combined effects of these environmental factors and the
mycobacterial response is to study the bacterial response in vivo.
Methodology/Principal Findings: We used the guinea pig model of tuberculosis to examine the bacterial proteome during
the early and chronic stages of disease. Lungs were harvested thirty and ninety days after aerosol challenge with Mtb, and
analyzed by liquid chromatography-mass spectrometry. To date, in vivo proteomics of the tubercle bacillus has not been
described and this work has generated the first large-scale shotgun proteomic data set, comprising over 500 unique protein
identifications. Cell wall and cell wall processes, and intermediary metabolism and respiration were the two major functional
classes of proteins represented in the infected lung. These classes of proteins displayed the greatest heterogeneity
indicating important biological processes for establishment of a productive bacterial infection and its persistence. Proteins
necessary for adaptation throughout infection, such as nitrate/nitrite reduction were found at both time points. The PE-PPE
protein class, while not well characterized, represented the third most abundant category and showed the most consistent
expression during the infection.
Conclusions/Significance: Cumulatively, the results of this work may provide the basis for rational drug design – identifying
numerous Mtb proteins, from essential kinases to products involved in metal regulation and cell wall remodeling, all present
throughout the course of infection.
Citation: Kruh NA, Troudt J, Izzo A, Prenni J, Dobos KM (2010) Portrait of a Pathogen: The Mycobacterium tuberculosis Proteome In Vivo. PLoS ONE 5(11): e13938.
doi:10.1371/journal.pone.0013938
Editor: Ramy K. Aziz, Cairo University, Egypt
Received April 19, 2010; Accepted October 7, 2010; Published November 11, 2010
Copyright:  2010 Kruh et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: These studies were performed with funding from the Bill and Melinda Gates Foundation (Grant # 42775, Mycobacterium tuberculosis in vivo) to KMD
and AAI (J. Belisle, PI) and funding from the NIH-NIAID (Contract #HHSN266200400091c, Tuberculosis Vaccine Testing and Research Materials) to KMD and AAI
(KMD, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Karen.Dobos@Colostate.edu
Introduction
The Mycobacterium tuberculosis (Mtb) bacillus has the ability to lie
dormant in the human body for decades, only progressing to active
disease in 5–10% of immunocompetent individuals. The organism
is transmitted through aerosols, and enters the pulmonary system
through inhalation. Within the lung, the bacillus can take up
residence inside an alveolar macrophage triggering the aggregation
of immune cells and the formation of a granuloma. During the
course of infection, granulomas play a dual role - serving as a niche
for the invading bacteria, whilst, protecting the host from active
disease. The population of granulomas within the infected host
consists of both primary and post-primary lesions. Primary
granulomas containing the inhaled founder strain are morpholog-
ically different from post-primary granulomas that have developed
through disseminated infection. This results in a heterogeneous
population of bacilli that are unique to the in vivo experience [1,2,3].
Substantial research has been dedicated to determining the
cellular architecture and molecular features of the host response,
including the granulomatous response, its formation and the role
of the host response in containing the bacterium. Until recently
few studies have focused on the significance of the bacterial
contribution within the infected host. Depictions of the mycobac-
terial proteome during infection thus far have been simulated
through in vitro studies – utilizing either infected cell culture [4,5]
or through the mimicry of hypoxic environments [6,7,8,9].
Further, models of nutrient starvation [10] and non-replicative
persistence (NRP) [11] have also contributed to the overall
dissection of the bacterium’s intracellular lifestyle. More recently,
bioinformatics was used to pool the overwhelming amount of data
from these studies, extracting the commonalities and proposing
new drug targets and vaccine candidates [12,13]. Specifically,
these studies illustrated the importance of proteins involved in the
transport of sulfur and cations, iron scavenging and nitrogen
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expression profile of Mtb during the in vivo infection provide a
more relevant picture of bacterium during infection [14], to date,
no thorough proteomic studies have been performed on in vivo
samples. In order to better understand the bacterial populations
within the lung, we believe a proteomic approach is necessary to
gain insight into the fundamental physiological state of Mtb during
infection and the mycobacterial response within the infected host
tissue.
Using the guinea pig model of aerosol infection, our study has
identified over 500 mycobacterial proteins present over the course
of infection. Our in vivo data gives solidarity to many of the in vitro
models of dormancy and is enhanced by the absence of artifacts
from in vitro growth in culture medium. Together, our results yield
a picture of the bacterial expression profile during infection.
Results and Discussion
Optimization of sample processing for mass
spectrometry
All Mtb protein identifications were derived from the lungs of
infected guinea pigs. Since homogenates were made from the
whole lung, all proteomic samples contained both host and
bacterial proteins. Based on growth curve data from infected
guinea pig lungs, 10–20 CFU seeded the lungs of each animal and
time-points earlier than 30 days were not addressed due to the
challenge of confident protein identification in lung tissue
containing less than 5 log10 bacilli [15]. The ratio of guinea pig
to mycobacterial cells were previously determined using uninfect-
ed lung tissue spikes with decreasing numbers of bacteria in order
to determine a lower limit of detection with our mass spectrometry
methods (data not shown). CFU data was determined for each
sample: day 30 samples averaged 5.77 log10 (60.19) and day 90
samples averaged 5.89 log10 (60.32) consistent with previous
observations [15]. Similarly, the pathological state of the lungs
demonstrated typical progression of chronic tuberculosis, with day
30 infected lungs demonstrating contained lesions consisting of
inflammation and areas of central necrosis (Figure 1A). Day 90
infected lungs demonstrated progression of disease with multiple
areas of inflammation and coalescing necrosis throughout the lung
along with secondary granulomas (Figure 1B) [16,17]. In either
case, a vast majority of each sample was composed of host
material. Thus, methodology was developed to significantly reduce
host proteins from overwhelming the analyses of Mtb proteins.
Similar in vivo samples previously analyzed by microarray
experiments utilized amplification of bacterial RNA or selective
analysis of transcripts to eliminate the burden of host RNA. For
proteomics, we applied a similar work-flow, whereby chromato-
graphic separation was used to amplify bacterial products via
reduction of the sample complexity prior to MS analysis, and
construction and interrogation of a smaller custom database
(rather than complex databases, ie NCBI or SwissProt) was used
for selective analysis of bacterial peptides.
Initial LC-MS/MS optimization was assessed with tryptic
digests of Mtb whole cell lysate (WCL) utilizing nanospray mass
spectrometry. The number of mycobacterial proteins identified
was found to directly correlate to the length of the elution segment
during chromatography. A short and shallow gradient (42 min)
did not allow for enough of a separation of host and bacterial
proteins. Since the host proteins were much more abundant, ion
suppression hindered the identification of many bacterial proteins.
In this study, multiple gradient conditions were evaluated, and it
was determined that with a peptide load of 50 ng, a 90 minute
linear gradient provided optimal separation (Table 1). Addition-
Figure 1. Representative photomicrographs of A) day 30, B) day
90post-infectionguineapiglungs,andC)uninfectedguineapig
lungs.Guineapigs were aerosolized with a low dose infectionof virulent
Mtb (H37Rv). Tissues were stained (H&E) to demonstrate differences in
granulomas based on size (primary granuloma, marked with the letter P)
and the absence (secondary granuloma, marked with the letter S) of a
necrotic core. Bars are 200 mm.
doi:10.1371/journal.pone.0013938.g001
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increased drastically with sequential injections of the same sample
(Figure 2). Therefore, all samples were run in triplicate. In
addition, the database used for interrogation contained the
predicted proteins of the Mtb H37Rv and mouse proteomes, so
that the host ion peaks would not be matched to the predicted m/z
for bacterial ions. Data was then subjected to a second
interrogation using a reverse database to further eliminate non-
mycobacterial specific spectra.
Composite analysis of in vivo Mtb proteomes
The sample set consisted of homogenates made from the lungs
of six animals, that were harvested 30 and 90 days after low dose
aerosol (LDA) infection (total of 12 samples, 6 biological replicates
for each time point). The concatenated Mtb-mouse database was
chosen due to the poor annotation of the guinea pig genome. Since
the goal of this study was to identify mycobacterial proteins, rather
than host, we felt that the confidence of our protein identifications
would be improved by the concatenation to this large mammalian
database, which is well-defined and includes over two hundred
thousand entries. We are confident in this database due to the
homology between the Mus musculus and Cavia porcellus proteins.
Indeed, the most commonly found host proteins, including:
albumin, calmodulin, actin, superoxide dismutase, were found
whether we used the mouse database or the poorly annotated
guinea pig database (data not shown). To reduce the false
discovery rate, two separate data filters were designed and applied
prior to pooling. The first filter removed proteins identified by
peptides that had low ratios of observed to theoretical MS/MS
ions – guaranteeing a certain amount of protein coverage and
removing bias from larger proteins. The second set of filters was
applied at the protein level, retaining only those proteins that were
present in 2 or more biological replicates. All filtered data were
pooled using the Scaffold program, which added another level of
stringency utilizing the Peptide and Protein Prophet statistical
analysis algorithms [18,19]. Proteins and peptides were disqual-
ified below a 90% threshold. Proteins identified by a single peptide
were removed from our analysis, while those identified by only two
peptides (in separate biological samples) were subject to manual
validation. To summarize, from the six 30-day time-point samples,
355,411 spectra were acquired. From these spectra, 1,598 were
matched to mycobacterial peptides within 310 proteins. Due to the
presence of mammalian tissue, the match ratio was low,
accounting for 0.4496% of the spectra. Likewise, from the six
90-day time-point samples, 287,843 spectra were acquired. From
these spectra, 2,336 were matched to mycobacterial peptides
within 323 proteins, accounting for 0.8116% of the total spectra.
This multi-filtered analysis provided a final list of 545 protein
identifications, ranging from 10 to 432 kDa with a pI range of 3.54
to 12.12. Between the 30 and 90-day samples, 222 and 235
proteins were uniquely identified and 88 proteins were common
between the two sample sets. (Figure 3; Supplementary Tables S1
and S2). As a negative control, six uninfected lung samples were
subjected to an identical analysis. Several falsely identified proteins
were removed from the final analysis based on the identification of
Mtb peptides in uninfected that were also found in our infected
samples. From this negative control, false discovery rates (FDRs) of
9.1% and 6.9% were calculated in the 30 and 90-day analysis
Figure 2. The percent of novel protein identifications taper after sequential injections of MS. Illustration showing the number of proteins
identified during 10 replicates (x-axis). The circles signify 50 ng injections of the same WCL digest peptide mixture (standard deviation=13.1).
Squares represent the additive effect of protein identifications after each replicate after combining the Sequest and Mascot result files in Scaffold (left
y-axis). The triangles depict the percentage (right y-axis) of unique protein identifications gained per additional replicate.
doi:10.1371/journal.pone.0013938.g002
Table 1. Summary LTQ method optimization.
Elution time (min)
# of Proteins Identified (standard
deviations)
42 43 (8.7)
60 78.7 (0.58)
90 93 (6.7)
120 117.3 (4.7)
Note: A constant amount (50 ng) of peptide was injected, while the elution
time (42–120 min) was altered in order to determine the optimal yield per
injection (number of injections=3). The increase in elution time generates
better resolution of the complex peptide mixture.
doi:10.1371/journal.pone.0013938.t001
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database analysis method and yielded similar FDRs, 11% and
6.8% for 30 and 90-day samples respectively. Since the FDRs
calculated from the potential false positives identified in the
uninfected samples are similar to the calculated FDRs from the
reverse database analysis, a high confidence (90%) for proteins
indentified in this analysis was retained.
Based on the TubercuList Web Server (http://genolist.pasteur.
fr/TubercuList) designations, all proteins were sorted by their
functional category (Figure 4A). Two functional groups, categories
3 (cell wall and cell processes) and 7 (intermediary metabolism and
respiration) comprised about half of the total data, representing
22.7% and 21% of the total identifications respectively. Interest-
ingly, there is little overlap between the day 30 and day 90 proteins
identified for these two categories, with only 13 identical proteins
(10.3%) and 12 identical proteins (10.3%) found in both day 30
and day 90 samples (Figure 4B and C).
A closer look at category 3 shows an abundance of membrane
transport proteins (Figure 5). This includes many members of the
metal-cation transporting ATPase family, including CtpV and
CtpB (copper), CtpD (possibly cadmium), CtpE (unknown), CtpF
(unknown), CtpG (unknown), CtbH (unknown) and CtpI (magne-
sium) – illustrating that the adjustment of cation levels is critical
within the host. Just upstream of CtpB (Rv0103), Rv0102 also
shows homology (by BLAST analysis) to copper resistance
transporters. In addition, 10 efflux pumps were identified and
were found to be particularly prevalent in the early stages of
infection. Conversely, proteins involved in the binding and
transport of phosphate were found entirely in the 90-day data
set. The presence and wide variety of pumps and transport
proteins during infection lends to the conjecture that the bacteria
may adapt to the host environment by scavenging resources and
altering the micronutrient levels.
Category 7 includes an assortment of proteins involved in
catabolism. While examination of the data demonstrated no
significant difference in hexose metabolism between day 30 and
90, significant differences were found in the later stages
metabolism, beginning with dehydrogenation of pyruvate through
the TCA cycle. Of the 10 proteins identified for this pathway, only
1 was specific to the 90-day samples and the spectra of the
remaining 9 proteins are overwhelmingly found in the 30-day
samples (Figure 5). This data supports that of others’ and indicates
a decrease in the preferred carbon nutrients, as well as a decrease
in phosphate during the chronic infection [20]. This also supports
the hypothesis that mycobacteria may breakdown lipids, rather
than carbohydrates, as a source of carbon and energy [21,22]. The
phospholipases C are noted virulence factors and are hypothesized
to breakdown host phospholipids for bacterial use [23]. Similarly,
Rv0183 – lysophospholipase, LipR (Rv3084) - a lipolytic esterase
and LipY (Rv3097) – a triacylglycerol lipase, were all expressed at
the 90-day time point. To obtain phosphorous for energy from the
host environment, Mtb may utilize two types of transport proteins,
a low-affinity, PitA and two high-affinity, PstS1 and PstS3
phosphate transporters [24], as well as a phosphate binding
lipoprotein. These were present during the chronic infection.
The third most abundant category consists of the acidic PE/
PPE proteins, which represent 16.2% of the total protein
identifications. It is important to note that the PE/PPE proteins
have numerous peptides that overlap or are highly similar. Thus
any ambiguities in the assignment of a PE/PPE peptide were
analyzed and validated. In this study, all peptides assigned to more
than one protein were only retained if the protein in question had
an additional two or more unique peptides. Unlike the categories
discussed above, this category contains the largest overlap - 37
proteins (45.7%), common between the 30 and 90-day samples.
However, from day 30 to day 90, there is also an increase of 7.4%
in respect to total proteins represented. This is the largest increase
in any of the categories. This increase is most evident in Tables 2
and 3, which show that of the ten most abundant proteins in each
sample set by spectral counting, two and five (30 and 90-day,
respectively) of these proteins are from the PE/PPE category. The
exact role of these proteins is unknown, but in general, these
proteins are thought to reside in the cell envelope and have been
implicated in increasing antigenic variation [25]. Many PE/PPE
proteins, such as PE-PGRS54, have been shown to be upregulated
in response to conditions such as hypoxia, exposure to H2O2 and
during NPR [26]. Of interest, it has been hypothesized that some
PE and PPE proteins may interact with each other after co-
expression from the same operon [27]. Following this notion, two
sets of proteins, PE-PGRS53/54 and PE-PGRS56/57, all highly
represented in the 90-day infection set, may be products of the
same operons.
Other dominant protein groups present in the in vivo
samples
Polyketide Synthesis and Virulence Lipids. The Mtb
genome encodes a variety of polyketide synthases (pks). These
large multi-domain proteins carry out a series of complex reactions
to construct complex lipids and metabolites. A total of 9 Pks
proteins were identified, including Pks4-9, 13, 15 and 17. Four of
the five PapAs or polyketide synthase associated proteins were also
identified. These proteins are co-regulated with the pks genes and
the mmpLs. Nine of the twelve MmpLs, large membrane-spanning
proteins involved in the translocation of lipids, were found in this
analysis, consistent with others’ hypotheses of their role during
infection and their active involvement in virulence [28,29]. One
such secreted virulence lipid, phthiocerol dimycocerosate (PDIM),
has been implicated in infection in mice, and more recently, genes
involved in PDIM synthesis have been shown as up-regulated in
response to lung surfactants [30,31]. While microarray data show
Figure 3. Venn diagram depicting the breakdown of proteins
identified at each time-point in this study. While a similar amount
of proteins were identified at each of the two infection time points, the
overlap is only 28% and 27% of the total identification in the 30 and 90-
day samples, respectively.
doi:10.1371/journal.pone.0013938.g003
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surfactants, the data presented here shows that many of these
proteins, including PpsA-D, Mas, PapA5, DrrA and MmpL7, are
present throughout in vivo growth. This is also contrary to
assumptions made with starvation models, in which many of
these genes were shown to be down-regulated [10]. Similarly,
sulfolipids (SL) have also been implicated to play a role in
virulence and at day 90, MmpL8 and PapA1 were found to be
present [32,33].
Cell Wall and Fatty Acid Biosynthesis. The mycobacterial
cell envelope is a thick, complex structure composed of covalently
linked mycolic acids, arbinogalactan and peptidoglycan [34]. The
production of mycolic acids (C70–C90) is the result of the two
types of fatty acid synthesis: de novo synthesis of short chain fatty
acids by the Fas protein and long chain fatty acid elongation of
FAS products by the FASII pathway. Unlike the Fas protein,
which like the pks proteins, is a large multifunctional protein, the
FASII pathway is composed of individual proteins working in
complex to carry out reactions such as condensation, keto-
reduction and dehydration. While the Fas protein was found
exclusively in the 30-day samples, the members of the FASII
pathway were found primarily in the 90-day samples. The FASII
pathway forms the long-chain fatty acyl precursors to mycolic
acids. One might speculate that the Fas products (C16–C26) are
shuttled into pathways, such as PDIM and SL biosynthesis, which
are required for virulence and in vivo survival. Interestingly, the
majority of the proteins involved in the synthesis of peptidogylcan
were found in the 30-day lung tissue and none of the
arabinogalactan biosynthesis proteins were detected. Only the
MurG protein showed a significant presence during chronic
infection (Figure 5). This may be indicative of MurG having dual
functions, first as the well-characterized last step of peptidoglycan
synthesis on the cytoplasmic side of the bacterial membrane
during the early infection and an additional role in cell elongation,
resulting in filamentous bacilli during the chronic stage [35,36].
While some residual replication or cell wall formation may be
occurring during infection, the cessation of mycolic acid assembly
early in infection is consistent with evidence that the bacteria can
Figure 4. A) Comparison of functional categories. The 30-day (blue), 90-day (red) and total identifications (green) were broken down by functional
categories. Categories codes are assigned by TubercuList (http://genolist.pasteur.fr/TubercuList/help/function-codes.html): 0=virulence, detoxifica-
tion & adaptation; 1=lipid metabolism; 2=information pathways; 3=cell wall & cell processes; 5=insertion sequences & phages; 6=PE/PPE;
7=intermediary metabolism & respiration; 8=unknown; 9=regulatory proteins; 10=conserved hypotheticals and 16=conserved hypotheticals with
an ortholog in M. bovis. B) Venn diagram showing the overlap between the 30-day and 90-day infection in category 3 and C) category 7.
doi:10.1371/journal.pone.0013938.g004
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hypothesis that the resumption of the FASII pathway in the 90-day
samples is indicative of the synthesis of free mycolic acids, perhaps
to create drug-tolerant persistent bacterial populations [38].
Metal Regulation. The impermeable mycobacterial cell wall
serves as a barrier to the import/export of micronutrients essential
for the catalytic activity for many enzymes. The production and
transport of mycobactin, either to the cell membrane or beyond, is
critical in the acquisition of host-derived iron. Production of this
polyketide siderophore and its ability to scavenge and chelate iron
is an essential part of intra-host survival for the bacillus [39,40,41].
Enzymes within the mycobactin synthesis pathway MbtA, B, C
Figure 5. Changes over the course of infection of representative pathways from categories 3 & 7. Each bar in the graph corresponds to
the normalized spectral count for each protein within the same category. Each color signifies the infection time-point: blue=30-day, red=90-day and
green=proteins found at both time-points, of which the area below the black line is the 30-day count and above equals the 90-day count. To the
right of each category is the percent breakdown of the total spectral counts in the 30 versus 90-day samples.
doi:10.1371/journal.pone.0013938.g005
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points. Likewise, copper is highly toxic but entirely essential for
maintaining activity of several mycobacterial enzymes. Therefore
its levels must be tightly regulated, using mechanisms such as
active export by the membrane protein, CtpV [42,43]. Similarly,
several other cation-transporting atpases were identified in this
study, as previously mentioned in the cell wall and cell wall
processes section. Due to the prevalence of the Ctp membrane
proteins in the infected lung samples, their functions may be
investigated further as potential drug targets. In support of this,
ctpG mutants were attenuated for virulence in the guinea pig,
supporting their role in this model [44]. CtpH and CtpV are found
at both infection time-points.
Protein Kinases and Nitrogen Assimilation. Of the eleven
serine/threonine-protein kinases (Pkns) found in the Mtb genome,
we found eight in the in vivo analysis, only three of which (PknA, B
and G) are noted to be essential proteins [45,46]. The inhibition of
protein kinases as part of drug therapy has already been noted; as
they have shown great utility in other fields, such as in the
treatment of certain cancers [47,48]. PknH is hypothesized to be
necessary for adapting to nitrite stress and development of the
chronic infection in the murine model [49]. This data corroborates
with the presence of this PknH exclusively at the 90-day infection
time point. Nitric oxide, generated by macrophages is a rich
source of nitrogen, which can be metabolised for incorporation
into various bacterial macromolecules. Proteins involved in
Table 2. The ten most dominant Mtb proteins within the 30-day Mtb-infected lung samples based on normalized spectral counts.
Rv# Protein Name Normalized Spectral Count Functional Category
30 Day 90 Day # Type
1 Rv2209 Rv2209 Probable Conserved Integral
Membrane Protein
27.9 0 3 Cell Wall & Cell Processes
2 Rv2315c Rv2315c Hypothetical Protein Rv2315c 27 23.5 10 Conserved Hypotheticals
3 Rv0860 FadB Probable Fatty Oxidation Protein 27 5.6 1 Lipid Metabolism
4 Rv0101 Nrp Probable Peptide Synthase 22.5 0 1 Lipid Metabolism
5 Rv3512 PE_PGRS56 PE_PGRS Family Protein 20.7 25.8 6 PE/PPE
6 Rv1360 Rv1360 Probable Oxidoreductase 18.9 11.2 7 Intermediary Metabolism &
Respiration
7 Rv0015c PknA Transmembrane Serine/
Threonine-Protein Kinase A
15.3 5.6 9 Regulatory Proteins
8 Rv3403c Rv3403c Hypothetical Protein Rv3403c 15.3 0 16 Conserved Hypotheticals with
an Orthologue in M. bovis
9 Rv3507 PE_PGRS53 PE_PGRS Family Protein 14.4 68.3 6 PE/PPE
10 Rv3859c GltB Probable Ferredoxin-Dependent
Glutamate Synthase
13.5 8.9 7 Intermediary Metabolism
& Respiration
Note: Early in the infection there are many functional categories represented. Many of the proteins are transient, having lower spectral counts or completely absent at
day 90. The major exceptions to this are the PE_PGRS proteins and the hypothetical protein Rv2315c.
doi:10.1371/journal.pone.0013938.t002
Table 3. The ten most dominant Mtb proteins within the 90-day Mtb-infected lung samples based on normalized spectral counts.
RV# Protein Name Normalized Spectral Count Functional Category
30 Day 90 Day # Type
1 Rv2244 AcpM Acyl Carrier Protein 0 118.7 1 Lipid Metabolism
2 Rv3507 PE_PGRS53 PE_PGRS Family Protein 14.4 68.3 6 PE/PPE
3 Rv2352c PPE38 PPE Family Protein 0 48.2 6 PE/PPE
4 Rv3447c Rv3447c Probable Conserved Membrane
Protein
9 . 9 3 9 . 2 3 C e l lW a l l&C e l lP r o c e s s e s
5 Rv2589 GabT 4-Aminobutyrate Aminotransferase 0 31.4 7 Intermediary Metabolism
& Respiration
6 Rv3508 PE_PGRS54 PE_PGRS Family Protein 0 31.4 6 PE/PPE
7 Rv2567 Rv2567 Conserved Hypothetical Alanine &
Leucine Rich Protein
2.7 30.2 10 Conserved
Hypotheticals
8 Rv3514 PE_PGRS57 PE_PGRS Family Protein 8.1 29.1 6 PE/PPE
9 Rv3512 PE_PGRS56 PE_PGRS Family Protein 20.7 25.8 7 Intermediary Metabolism
& Respiration
10 Rv2315c Rv2315c Hypothetical Protein Rv2315c 27 23.5 10 Conserved Hypotheticals
Note: The chronic state of infection is dominated by an abundance of proteins from the PE/PPE category.
doi:10.1371/journal.pone.0013938.t003
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identified in a hypoxia model by microarray analysis (along with
narK2), as well as by in situ hybridization in human lungs [50,51].
Our proteomic analysis shows the presence of not only the NarX
protein, but in addition, 4 of the 6 of the proteins from the nitrate
reductase family from the narGHJI and narK2X operons, consistent
with their role in microaerophilic conditions [7,51,52]. The narU
gene product, which plays a role in nitrite excretion, was also
found, as was the NirB, nitrite detoxification protein. While this
protein class is present throughout infection, an increase in of most
of these proteins during the chronic infection may be due to the
effects of hypoxia (Figure 5).
Possible relationships between proteomic and
microarray datasets
The proteomic analysis of Mtb infected guinea pig lungs 30 and
90-days post-aerosol challenge provides a description of proteins
present during the establishment and maintenance of infection.
Prior to this study, the majority of the information known about
the bacterial state during hypoxia or infection was gleaned from
correlative microarray studies. It has been noted that due to post-
transcriptional events, the relationship between the amount of
mRNA and protein is not 1:1 [53]. This was very evident when
comparing the 30 and 90-day proteomic data to that of the gene
expression data sets from the well-characterized in vitro models of
NRP and starvation. For example, the Muttucumaru et al. data
set, which summarizes the changes cells undergo in the transition
from aerobic growth to that of NRP1 (microaerophilic) and NRP2
(anaerobic) stage, showed a 6.8% overlap between the genes
upregulated in NRP1/2 and our 30/90-day in vivo analysis
(Table 4) [54]. The commonalities include: narK2 and narH (nitrate
reductase), ppsB and mas (PDIM synthesis), ctpV (copper transport)
mbtB (mycobactin synthesis) and several ppe genes. Similar trends
in upregulation were apparent in the Voskuil et al microarray
analysis of the stationary phase and NRP models, the Rachman et
al microarray analysis of Mtb in infected lungs and even the Cho et
al ICAT study on in vitro NRP (Table 4) [8,11,55]. While Cho’s
study identified representatives from important up-regulated
pathways, the proteomics methodology employed in our study
recognized several more members of each of these pathways –
reinforcing their importance in vivo. In addition to those
similarities, major fundamental differences exist between micro-
array data sets from in vitro studies and the proteomic data
described in this study. Specifically, a large amount of chaperones
and detoxification proteins were identified in the in vitro models. In
fact, the single most common finding in the in vitro scenarios,
including both Rachman and Cho studies, is the upregulation of
hspX (Rv2031) [11,55]. It is very likely that HspX is present in vivo
– however, based on our findings, it is either rapidly exported from
the lung or its mass spectra are obscured in our study.
Interestingly, the starvation model [10] appears the least similar
to the in vivo results described in this study. In fact, the results
appear to be reversed – the profile of genes found down regulated
in response to starvation are more similar to our infection model
than those found to be up-regulated. Perhaps in the lung of the
host, the bacteria are not nutrient restricted at all. Since the
sequencing of the Mtb genome in 1998, it has been known that Mtb
contains an unusually large number of proteins involved in lipid
metabolism [25]. Many FadD and FadE proteins are present in
the in vivo data set, thus, it is likely that the bacteria are able to
breakdown host lipids in order to utilize them as nutrients [56].
Contrary to our results, the Betts’ model shows PDIM synthesis to
be decreased, as well as down-regulation of several genes,
including: glcB, pknB, phoS1 and fas – many of which have been
Table 4. Overlap of our study with a sampling of in vitro studies.
Present in 30-day
(% of 30-day total)
Present in 90-day
(% of 90-day total)
Present in both
(% of ‘both’ total)
Present in either
(% of ‘either’ total)
This Study 30-day 310
(100%)
- - 310
(57.2%)
90-day - 323
(100%)
-3 2 3
(60.1%)
Total - - 88
(100%)
545
(100%)
Rachman
[55]
Total=188 12
(3.9%)
16
(5.0%)
6
(6.8%)
22
(4.0%)
Muttucumaru
[54]
NRP1 & NRP2 Total=299 27
(8.7%)
21
(6.5%)
10
(11.4%)
38
(7.0%)
Voskuil
[8]
Stationary Phase &
Low Oxygen
Total=116 5
(1.6%)
9
(2.8%)
4
(4.5%)
9
(1.7%)
Rohde
[62]
Macrophage
Infection - 24 hours
Total=115 5
(1.6%)
8
(2.5%)
2
(2.3%)
11
(2.0%)
Cho
[11]
NRP1 - ICAT Total= 87 8
(2.6%)
8
(2.5%)
1
(1.0%)
15
(2.8%)
NRP2 - ICAT Total=111 19
(6.1%)
14
(4.3%)
4
(4.5%)
29
(5.3%)
Betts
[10]
Starvation
Model - Up
Total=44 1
(0.3%)
1
(0.3%)
0
(0.0%)
2
(0.4%)
Starvation
Model - Down
Total=70 7
(2.3%)
7
(2.2%)
5
(5.7%)
9
(1.7%)
Note: For the most part, in vitro studies have less than 5% similarity with the proteomic data in this study. The two studies depicting changes found during NRP1/2 by
Muttucumaru and Cho show the highest similarity to this study.
doi:10.1371/journal.pone.0013938.t004
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a hypothetical protein found to be in our preliminary 10 most
abundant proteins list at day 30 (Table 2), is shown to be down-
regulated in the starvation model [10]. However, by day 90 this
protein is completely absent and may be potentially related to the
decrease in a nutrient in the lung.
Much of the literature defining the bacterial state during NRP
has been based on microarray studies, in which changes in mRNA
levels in response to the implementation of stresses on cultured Mtb
were monitored. While it is important to tease out which pathways
may be upregulated due to each stress the bacteria faces in the
host, it is equally as important to establish the combined and
actual effects of intra-host pressure. In this study, none of the
simulated in vitro (model) environments accurately reflect the
protein profile within the lung – even the ‘‘multiple stress
dormancy model’’ [59]. This is not entirely surprising; in vitro
cultures include a different set of variables resulting in bacterial
stress, such as nutrients are static and can be exhausted, toxic
bacterial byproducts can build up, and physical space is limiting.
Likewise, even tissue culture experiments yield an incomplete
picture, in that they are missing more complex immunological
influences. Perhaps the most important difference is that in vitro
studies focus on a clonal population, while in the in vivo experience
different populations exist – a major contributing factor that has
hindered the progress of treatment. In order to tease out which
proteins vary across the various bacterial populations and host
environments, in future studies, primary and secondary granulo-
mas will be compared to uninvolved tissue.
Lastly, we acknowledge that our described in vivo proteome lacks
the identification of the major secreted proteins. This was
unexpected, since in all previous in vitro analyses by ourselves
and others [6,60,61], secreted/stress response proteins such as
GroEL, HspX and DnaK, were highly abundant. Similarly,
during the development of our mass spectrometry methodology,
we utilized uninfected lung tissue spiked with 10
6 gamma-
irradiated (dead) Mtb and in this analysis the secreted proteins
and several chaperones remained dominant (data not shown).
Likewise, microarray analysis of Mtb from macrophage culture,
show transcripts of the stress-associated proteins in high abun-
dance [62]. Clearly, there is a difference between mock-infected
lung tissue, cell culture-based analyses, and lung tissue obtained
from an actual infection. Since our proteomics was performed on
whole lung homogenates, it is likely that the exported proteins
were not identified because these proteins are not simply secreted
by the bacillus and retained at the site of infection; rather we
hypothesize that these proteins are trafficked to the draining
lymph node, serving as important T-cell antigens. These secreted
proteins, therefore, may not be valid drug targets because they are
not directly associated with the site of infection. However, their
role as potential biomarkers, diagnostic reagents, or vaccine
candidates remains. In addition to phagocytosis-mediated export
of secreted proteins from the lung, some proteins may directly
traffic to the blood, sputum, or other bodily fluids. Indeed,
members of the antigen-85 complex (Rv3804c, Rv1886c and
Rv0129c) have been detected in serum and cerebral spinal fluid
[63,64]. Further, some secreted mycobacterial products may be
shuttled away in exosomes; as is the case described for the 19 kDa
liproprotein (Rv3763) and lipoarabinomannan (LAM) [65].
Final remarks
In this study, over 500 Mtb proteins present at 30 and 90 days
post infection are described. This description provides a picture of
the Mtb proteome in mammalian lungs. The exclusion of a protein
from either sample list does not rule out its presence. These
samples are highly complex, containing both host and bacterial
peptides. Thus it is likely that only the most dominant Mtb proteins
(where dominance is reflective by quantity and capacity for mass
spectrometry detection based on the physiochemical ionization
properties of the protein) are described here. One of the flaws of
large-scale shotgun proteomic studies is that dominant peptides
can skew the results in a manner that causes some proteins to
remain undetected. Thus, tables 3 and 4 contain the proteins
observed based on the abundance of unique and repetitively
sequenced peptides from one protein. While this is an accepted
method to glean which proteins are more dominant relative to
other proteins identified in a given sample, their absolute
abundance has not been validated. Most of the spectral counts
(the spectral counts for each protein identified in this study can be
found in Supplementary Table S3.) mentioned in our study are
significantly lower (ten-fold) than the dominant host proteins,
which are in the hundreds (data not shown). This is entirely
expected and is reflective of the nature of the sample – the infected
lung contains few bacteria in relation to host cells. Validation of
any of the proteins or pathways in question can be performed with
a quantitative mass spectrometry technique, like multiple reaction
monitoring (MRM); these studies are currently being developed in
our laboratory to validate some of our findings.
This proteomic study on infected lung homogenates has
supplied a long list of mycobacterial proteins that are present
during infection. The most challenging facet to treating tubercu-
losis is that there are multiple populations of Mtb within the lung.
Thus, it is not surprising that our data does not correlate with any
one in vitro model. The Mtb-infected lung comprises a heteroge-
neous and dynamic population of bacteria. One additional source
of heterogeneity is the contribution of organisms that have
infiltrated from other infection sites, such as the spleen. It is
believed that after seeding the spleen, organisms can re-enter the
lung as secondary infection sites [2]. Therefore, it is highly likely
that these organisms are also sampled in our 90-day post-infection
analysis, in addition to those retained in the lung throughout the
course of infection. This aspect is beneficial when defining drug
targets. We believe that several of the proteins identified in our
analysis will give us clues to which pathways and biosynthetic
processes of Mtb might be worth targeting during an infection. It is
difficult to determine which, of the hundreds of proteins identified
are important from this study. The comparisons of our dataset to
others’ afford some conjecture (Table 4). Few studies have looked
at specific factors contributing to Mtb survival in the guinea pig
model of infection. One study did explore survival rates of
attenuated Mtb and identified 18 mutants with reduced fitness in
the guinea pig [44]. Two of the eighteen gene products, Rv1798
and ctpG were identified in this study. As part of our future
undertakings, we hope to further mine which of these aspects of
Mtb physiology persist in specific Mtb lesions through continued
comprehensive and targeted proteomic profiling during infection
in an effort to define novel, specific targets that lead to advances in
vaccine and drug discovery efforts.
Materials and Methods
Mtb samples and cultures for guinea pig infection
M. tuberculosis H37Rv whole cell lysate was provided through the
NIAID contract ‘‘Tuberculosis research materials and vaccine
testing (HHSN266200400091c). For guinea pig infections, Mtb
H37Rv was initially grown for three passages as a pellicle on
Proskauer & Beck media (5 g KH2PO4, 5 g asparagine, 0.6 g
MgSO4.7H2O, 2.5 g magnesium citrate, 20 mL glycerol, 1 L
water, pH 7.8) medium to produce seed stocks. Working stocks
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stocks in P&B medium with 0.1% Tween
-80. Working stocks were
prepared at the mid-log phase, and aliquots were stored at –80uC.
Low dose aerosol (LDA) infection of guinea pig
Out-bred female Hartley guinea pigs weighing 450–500 grams
were purchased from Charles River Laboratories (Wilmington,
MA). Guinea pigs were maintained under ABSL-3 barrier
conditions in isolator cages (Thoren, Hazleton PA). Bacterial
suspensions described above were used to infect 12 guinea pigs
with H37Rv by the LDA method (approximately 10 CFU) with a
Madison Chamber [66]. In addition, a small aliquot of the
suspension is plated on 7H11 media to confirm dose of aerosolized
bacilli used in each infection. After infection, individuals in each
group are weighted weekly and checked daily for signs of disease.
The Karnofsky scale for pain and distress was used to evaluate the
well being of each guinea pig. Guinea pigs with a score of 8 or
more were euthanized. CFUs were determined by plating organ
homogenates onto nutrient 7H11 agar supplemented with OADC.
Colonies were enumerated after 21-days incubation at 37uC. All
animals were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies, and all animal work was approved by the
appropriate committee (IACUC #06-239A). The aforementioned
experimental procedures were approved by the Colorado State
University Institutional Animal Care and Use Committee.
Preparation of guinea pig lung homogenates
At the 30 or 90-day post-infection time point, guinea pigs were
sacrificed and the right cranial lung lobe was used for bacilli
counts. The remaining lobes were added to 3 mL of PBS and
subject to 4 rounds of homogenization with an Omni MultiMix
200. Samples were removed and homogenization tubes were
rinsed with an additional 1 mL of PBS. The total homogenate was
then treated with collagenase H (final concentration: 0.7 mg/mL)
and DNase (final concentration: 30 mg/ml) for 1 hour at 37uC,
shaking. Homogenates were delipidated with 2 rounds of
chloroform:methanol (1:1). The remaining cell pellets were
sonicated in PBS and the product was centrifuged at 14k rpm
for 10 minutes to remove insoluble particles. The supernatant was
mixed with collagen-agarose to remove any residual collagenase.
The remaining protein was quantified by bicinchoninic acid (BCA)
assay (Pierce). As a control, 6 uninfected guinea pigs were
sacrificed on the same day as the 30-day infected guinea pigs. The
lungs were processed identically to the infected lungs.
Processing of proteins isolated from lung tissue
10 mg of each sample lysate was denatured in 6 M guanidine
hydrochloride, reduced with 10 mM DTT and alkylated with
100 mM iodoacetamide. After overnight micro-dialysis in 10 mM
ammonium bicarbonate the samples were digested with trypsin
(1:50, trypsin:lysate) in 10% acetonitrile (ACN) overnight at 37uC.
Digests were dried and resuspended in LTQ loading buffer, 3%
ACN and 0.1% formic acid. All digests are performed in
deplasticized tubes to reduce plastic polymer contamination.
Mass Spectrometry of tryptic peptides
All samples were injected at a concentration of approximately
50 – 100 ng/mL. Peptides were purified and concentrated using an
on-line enrichment column (Agilent Zorbax C18, 5 mm,
560.3 mm column, Agilent 1100 nanoHPLC,). Subsequent
chromatographic separation was performed on a reverse phase
nanospray column (Zorbax C18, 5 mm, 75 mmI D6 150 mm
column). Samples were eluted into a LTQ linear ion trap (Thermo
Scientific) using a flow rate of 300 nL/min with the following
gradient profile: 0% B for 0–5 min, 0–15% B for 5–8 min, 15–
55% B for 8–98 min, and 55–100% B for 98–103 min (A=3%
ACN, 0.1% formic acid; B=100% ACN, 0.1% formic acid). This
elongated method has been optimized to separate complex
samples, such as whole cell lysate. Mass spectra are collected over
a m/z range of 200–2000 Da using a dynamic exclusion limit of 2
MS/MS spectra of a given mass for 30 s (exclusion duration of
90 s). Compound lists of the resulting spectra were generated using
Bioworks 3.0 software (Thermo Scientific) with an intensity
threshold of 5,000 and 1 scan/group. All samples were run in
triplicate.
Database searching
All tandem mass spectra (.raw files) were extracted by
LCQ_DTA.exe (Thermo Scientific) for subsequent loading into
the Mascot (Matrix Science, London, UK; version: 2.1 Mascot)
[67] MS/MS search engine or into Bioworks Browser (version
3.3.1 SP1) for subsequent analysis with Sequest (Thermo Finnigan,
San Jose, CA; version SRF v.5). Mascot was set up to search a
customized database (created on 05/06/08) composed of the
Mycobacterium tuberculosis H37Rv FASTA (GenBank accession
number AL123456, release R9, 3,998 protein genes) concatenated
to the IPI Mouse database (International Protein Index - http://
www.ebi.ac.uk/IPI/IPIhelp.html), which contains 222,498 entries.
Sequest and X!Tandem (Version 2007.01.01.1) were set up to
search only the Mycobacterium tuberculosis H37Rv database listed
above. All searches were performed assuming trypsin digestion,
with a fragment ion mass tolerance of 1.00 Da, a parent ion
tolerance of 3.00 Da. Mascot and Sequest searches allowed for 1
and 5 missed cleavages, respectively. Oxidation of methionine
(+16) and the iodoacetamide derivative of cysteine (+57) were
specified as variable modifications.
Criteria for Protein Identification
Sequest result files were subject to two filters. At the peptide
level, peptides were excluded if the ratio of observed to theoretical
peptides was ,0.2, when the theoretical was less than 100, or a
ratio of ,0.1, when the theoretical value was greater than or equal
to 100. This step removed 15–30% of the peptides per run. The
second filter was applied at the protein level. Peptides from a single
technical replicate corresponding to a single protein were pooled.
Those proteins not represented in at least two biological replicates
were dropped. Lastly, peptides not present in at least two
biological replicates were dropped and the resulting single peptide
identifications were dropped. The reduced Sequest results, as well
as the Mascot results were compiled in Scaffold (version 2.02.01,
Proteome Software Inc., Portland, OR) in order to validate MS/
MS based peptide and protein identification. Peptide identifica-
tions were accepted if they could be established at greater than
90% probability as specified by the Peptide Prophet algorithm
[18]. Protein identifications were only accepted if they could be
established at greater than 90% probability and contained at least
two identified peptides. Protein probabilities were assigned by the
Protein Prophet algorithm [19]. At this stage, all remaining
peptide identifications were screened for presence in multiple
biological replicates and those proteins identified by two peptides
were subject to manual validation for final confirmation. The final,
compressed files and accepted spectra are available for review
through Tranche (https://proteomecommons.org/tranche/; enti-
tled ‘‘30day_mudpitted_condensed’’ and ‘‘90day_mudpitted_con-
densed’’).
Mtb Proteome In Vivo
PLoS ONE | www.plosone.org 10 November 2010 | Volume 5 | Issue 11 | e13938Normalization of Spectral Counts
In order to compare the two time-points, the spectral counts
were normalized. To do this, the average number of spectra in
both 30 and 90-day analysis (321,627) was divided by the 30-day
total (355,411) and the 90-day-total (287,843) yielding the values
0.9 and 1.12, which were used as multipliers to the spectral counts
in the 30 and 90-day samples respectively [68].
Calculation of False Discovery Rates (FDRs)
In order to calculate the FDR for each of the time-point data
sets, all .raw files were searched against a decoy database. Decoy
databases contain a reversed version of the proteins included in
either the customized database composed from the Mycobacterium
tuberculosis H37Rv FASTA (for Sequest), as well as concatenated to
the reverse IPI Mouse database (for Mascot). The resulting files
were pooled in Scaffold and the analysis was identical to that
described above. The number of proteins matched to the reverse
database, 35 and 23, in the 30 and 90-day data sets respectively, is
equal to the number of false positives (FP). The equation for the
FDR is FP/TP, where TP is the number of total positives found in
each data set (318 for day 30 and 334 for day 90). Therefore, the
FDRs are 11% and 6.8% for the 30 and 90-day data sets,
respectively. In addition, uninfected guinea pig lungs were
subjected to the identical protocol including lung homogenization
and process through mass spectrometry and analysis. This analysis
identified 74 Mtb proteins, however only 11 of these proteins
contained peptides identified in our 30 and 90-day infected lung
samples. These 11 proteins were considered false positives and
removed from the analysis of infected tissues. Of the remaining 63
‘‘Mtb proteins’’ (Supplementary Table S4, Supplementary Figure
S1A), 29 and 23 were identified in the 30 and 90-day infected lung
samples, respectively. However, none of the peptides used to make
these identifications were identical to those found in infected lung
tissue, thus, these proteins were retained in our study (Supple-
mentary Figure S1B). By retaining these proteins, an FDR of 9.1%
and 6.9% for day 30 and 90-day samples, respectively, is derived.
This rate is compares with the FDR calculated by decoy method
described above, supporting the traditional statistical validation
used.
Western Blots
For validation of proteins, two antibodies against Mtb proteins
identified in this study, anti-GlcB and anti-PstS1, were available
and provided through the NIAID contract, ‘‘Tuberculosis research
materials and vaccine testing’’ (HHSN266200400091c). 10 mgo f
each lung homogenate sample and the ECL Plex Fluorescent
Rainbow Marker (GE) Healthcare) were resolved by SDS-PAGE
on a 4 – 12% Bis-Tris Mini Gel (Invitrogen) in MES Buffer,
followed by transfer to a PVDF membrane (Hybond LFP, GE
Healthcare). Western blot procedure was performed as recom-
mended by the manufacturer. ECL Plex Cy2 conjugated anti-
mouse IgG was used as the secondary antibody. Blots were
scanned using the Typhoon scanner (GE Healthcare), and bands
were analyzed using ImageQuant
TM TL software. Mtb whole cell
lysate (2.5 mg) was used as the positive control (Supplementary
Figure S2).
Supporting Information
Table S1 Mtb proteins identified in 30-day infected guinea pig
lungs. Data includes number of unique peptides identified for each
protein.
Found at: doi:10.1371/journal.pone.0013938.s001 (0.10 MB
XLS)
Table S2 Mtb proteins identified in 90-day infected guinea pig
lungs. Data includes number of unique peptides identified for each
protein.
Found at: doi:10.1371/journal.pone.0013938.s002 (0.10 MB
XLS)
Table S3 Spectral counts of the Mtb proteins identified in 30-
day and 90-day infected guinea pig lungs.
Found at: doi:10.1371/journal.pone.0013938.s003 (0.22 MB
XLS)
Table S4 Spectral Counts of the Mtb Proteins Identified in
Uninfected Guinea Pig Lungs.
Found at: doi:10.1371/journal.pone.0013938.s004 (2.57 MB
XLS)
Figure S1
Found at: doi:10.1371/journal.pone.0013938.s005 (0.30 MB TIF)
Figure S2 Fluorescent western blots of GlcB (80.4 kDa) and
PstS1 (38.2 kDa) at 30 and 90 day infection time points. C: positive
control; U: uninfected guinea pig; 1-6: infected guinea pigs.
Found at: doi:10.1371/journal.pone.0013938.s006 (0.26 MB TIF)
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